mercredi 1 juin 2016

Onco Actu du 1er juin 2016

2.4 Etiologie - Portables, ondes e-m

NTP and Brain Tumor Rates [Microwave News]

The New Health Care: Why It’s Not Time to Panic About Cellphones and Cancer [NY Times]

2.6 Etiologie - Environnement

EU set to consider temporary extension of glyphosate license over cancer row [Reuters]

3.1 Tabac

Linda Bauld: The road to standardised tobacco packaging in the UK [BMJ Blogs]

World No Tobacco Day 2016: how plain packs are helping Australia’s record-low smoking rates [Cancer Research UK]

Cigarette plain packs to 'go global' [BBC News]

White House scrapped FDA plan to restrict flavored e-cigarettes [Reuters]

5. Traitements

Treatment 'breakthrough' in man with advanced skin cancer [NHS Choices]

Statins 'could be valuable addition to breast cancer treatment' [The Guardian]

5.2 Pharma

Daiichi Sankyo to not proceed with lung cancer study [Reuters]

5.2.1 Pharma - Partenariats

Bayer collaborates with U.S. National Surgical Adjuvant Breast and Bowel Project (NSABP) to Investigate Stivarga® (Regorafenib) as Additional Adjuvant Therapy in Colon Cancer [Bayer]

5.2.2 Pharma - Fusions & Acquisitions

Celator Gets Bought, As Stock Rockets From $1.68 To $30.25 In Two Months [Forbes]

Celator Parlays Leukemia Drug Data into $1.5B Buyout From Jazz Pharma [Xconomy]

5.2.3 Pharma - économie

Genmab bags $30M milestone from J&J as Darzalex money machine fires up [FierceBiotech]

5.3 Traitements - FDA, EMA,...

Regulatory information - A new operating model for procedure management to improve support for evaluation procedures [EMA]

5.3.4 Traitements - AMM (FDA, EMA)

EC approves ibrutinib for patients with newly diagnosed CLL [European Pharmaceutical Review]

5.4 Traitements - Economie

Nice rejects Janssen's Imbruvica in draft guidance [Pharmafile]

Money-back guarantee: the new trend in drug and device marketing [STAT]

5.5 ASCO

Vice President Biden to Discuss National Cancer Moonshot Initiative at 2016 American Society of Clinical Oncology (ASCO) Annual Meeting [ASCO]

Five Storylines To Watch At ASCO [Forbes]

5.5.4 ASCO (immunothérapies)

Kite Pharma to Highlight Key Data from Engineered CAR T Cell Therapy Pipeline at the 2016 American Society of Clinical Oncology Annual Meeting [Kite]

6. Lutte contre les cancers

University of Maryland Cancer Center Earns Comprehensive Designation [The Cancer Letter]

6.1 Observation

American Death Rate Rises for First Time in a Decade [NY Times]

6.10 Politiques

After meeting Nobel laureates, French president backs off ‘suicidal’ science cuts [Science]

6.11 Patients

At Stanford’s new cancer center, patients interview every new hire [Quartz]

6.5 Médecines alternatives

He’s 20. Has brain cancer. And is caught in the crossfire between the FDA and a renegade doctor [STAT]

6.6 Publications

Why Sci-Hub Will Win [Medium]

Elsevier is tricking authors into surrendering their rights [it is NOT junk]